Clinical Trial Update: RGD-PET-CT in Cancer Angiogenesis [Phase 2]

View source ↗

Summary

Phase 2 trial of RGD-PET-CT imaging for cancer angiogenesis in renal cell carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: TERMINATED